cbdMD, Inc.
YCBD
$0.72
-$0.01-1.49%
AMEX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -0.66% | -1.50% | -7.80% | -9.22% | -18.02% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -0.66% | -1.50% | -7.80% | -9.22% | -18.02% |
| Cost of Revenue | 1.94% | -3.53% | -2.18% | -8.37% | -12.93% |
| Gross Profit | -2.28% | -0.23% | -11.04% | -9.72% | -20.90% |
| SG&A Expenses | -2.14% | -9.74% | -18.41% | -25.60% | -28.41% |
| Depreciation & Amortization | -7.78% | -2.06% | -24.72% | -28.33% | -31.80% |
| Other Operating Expenses | 18.68% | 17.12% | -88.16% | -90.25% | -79.67% |
| Total Operating Expenses | -0.46% | -6.34% | -21.49% | -27.82% | -29.60% |
| Operating Income | -1.14% | 34.77% | 69.51% | 82.65% | 67.44% |
| Income Before Tax | 13.00% | 44.84% | 92.21% | 99.27% | 86.54% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 13.00% | 44.84% | 92.21% | 99.27% | 86.54% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 13.00% | 44.84% | 92.21% | 99.27% | 86.54% |
| EBIT | -1.14% | 34.77% | 69.51% | 82.65% | 67.44% |
| EBITDA | -10.00% | 52.14% | 85.26% | 98.01% | 78.56% |
| EPS Basic | 85.13% | 78.96% | 96.67% | 96.21% | 90.80% |
| Normalized Basic EPS | 84.29% | 88.28% | 96.01% | 94.58% | 86.07% |
| EPS Diluted | 85.13% | 78.96% | 96.67% | 96.22% | 90.80% |
| Normalized Diluted EPS | 84.29% | 88.28% | 96.01% | 94.58% | 86.07% |
| Average Basic Shares Outstanding | 945.52% | 649.51% | 515.06% | 136.73% | 143.97% |
| Average Diluted Shares Outstanding | 945.52% | 649.51% | 515.06% | 136.73% | 143.97% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |